These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28284873)

  • 1. Establishing a reference dataset for the authentication of spinal muscular atrophy cell lines using STR profiling and digital PCR.
    Stabley DL; Holbrook J; Harris AW; Swoboda KJ; Crawford TO; Sol-Church K; Butchbach MER
    Neuromuscul Disord; 2017 May; 27(5):439-446. PubMed ID: 28284873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of SMN1 to SMN2 gene conversion events and partial SMN1 gene deletions using array digital PCR.
    Stabley DL; Holbrook J; Scavina M; Crawford TO; Swoboda KJ; Robbins KM; Butchbach MER
    Neurogenetics; 2021 Mar; 22(1):53-64. PubMed ID: 33415588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intragenic mutations in SMN1 may contribute more significantly to clinical severity than SMN2 copy numbers in some spinal muscular atrophy (SMA) patients.
    Yamamoto T; Sato H; Lai PS; Nurputra DK; Harahap NI; Morikawa S; Nishimura N; Kurashige T; Ohshita T; Nakajima H; Yamada H; Nishida Y; Toda S; Takanashi J; Takeuchi A; Tohyama Y; Kubo Y; Saito K; Takeshima Y; Matsuo M; Nishio H
    Brain Dev; 2014 Nov; 36(10):914-20. PubMed ID: 24359787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a 4-color multiplexing spinal muscular atrophy (SMA) genotyping assay on a novel integrated digital PCR instrument.
    Jiang L; Lin R; Gallagher S; Zayac A; Butchbach MER; Hung P
    Sci Rep; 2020 Nov; 10(1):19892. PubMed ID: 33199817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.
    Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H
    Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Reference Materials for Spinal Muscular Atrophy Genetic Testing: A Genetic Testing Reference Materials Coordination Program Collaborative Project.
    Prior TW; Bayrak-Toydemir P; Lynnes TC; Mao R; Metcalf JD; Muralidharan K; Iwata-Otsubo A; Pham HT; Pratt VM; Qureshi S; Requesens D; Shen J; Vetrini F; Kalman L
    J Mol Diagn; 2021 Jan; 23(1):103-110. PubMed ID: 33197628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical phenotypes of spinal muscular atrophy patients with hybrid SMN gene.
    Niba ETE; Nishio H; Wijaya YOS; Lai PS; Tozawa T; Chiyonobu T; Yamadera M; Okamoto K; Awano H; Takeshima Y; Saito T; Shinohara M
    Brain Dev; 2021 Feb; 43(2):294-302. PubMed ID: 33036822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplex Droplet Digital PCR Method Applicable to Newborn Screening, Carrier Status, and Assessment of Spinal Muscular Atrophy.
    Vidal-Folch N; Gavrilov D; Raymond K; Rinaldo P; Tortorelli S; Matern D; Oglesbee D
    Clin Chem; 2018 Dec; 64(12):1753-1761. PubMed ID: 30352867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporating Spinal Muscular Atrophy Analysis by Next-Generation Sequencing into a Comprehensive Multigene Panel for Neuromuscular Disorders.
    Tan CA; Westbrook MJ; Truty R; Kvitek DJ; Kennemer M; Winder TL; Shieh PB
    Genet Test Mol Biomarkers; 2020 Oct; 24(10):616-624. PubMed ID: 32721234
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetics of low spinal muscular atrophy carrier frequency in sub-Saharan Africa.
    Sangaré M; Hendrickson B; Sango HA; Chen K; Nofziger J; Amara A; Dutra A; Schindler AB; Guindo A; Traoré M; Harmison G; Pak E; Yaro FN; Bricceno K; Grunseich C; Chen G; Boehm M; Zukosky K; Bocoum N; Meilleur KG; Daou F; Bagayogo K; Coulibaly YI; Diakité M; Fay MP; Lee HS; Saad A; Gribaa M; Singleton AB; Maiga Y; Auh S; Landouré G; Fairhurst RM; Burnett BG; Scholl T; Fischbeck KH
    Ann Neurol; 2014 Apr; 75(4):525-32. PubMed ID: 24515897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multisite Evaluation and Validation of a Sensitive Diagnostic and Screening System for Spinal Muscular Atrophy that Reports SMN1 and SMN2 Copy Number, along with Disease Modifier and Gene Duplication Variants.
    Milligan JN; Larson JL; Filipovic-Sadic S; Laosinchai-Wolf W; Huang YW; Ko TM; Abbott KM; Lemmink HH; Toivonen M; Schleutker J; Gentile C; Van Deerlin VM; Zhu H; Latham GJ
    J Mol Diagn; 2021 Jun; 23(6):753-764. PubMed ID: 33798739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in therapeutic development for spinal muscular atrophy.
    Howell MD; Singh NN; Singh RN
    Future Med Chem; 2014 Jun; 6(9):1081-99. PubMed ID: 25068989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comparative Study of SMN Protein and mRNA in Blood and Fibroblasts in Patients with Spinal Muscular Atrophy and Healthy Controls.
    Wadman RI; Stam M; Jansen MD; van der Weegen Y; Wijngaarde CA; Harschnitz O; Sodaar P; Braun KP; Dooijes D; Lemmink HH; van den Berg LH; van der Pol WL
    PLoS One; 2016; 11(11):e0167087. PubMed ID: 27893852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZPR1 prevents R-loop accumulation, upregulates SMN2 expression and rescues spinal muscular atrophy.
    Kannan A; Jiang X; He L; Ahmad S; Gangwani L
    Brain; 2020 Jan; 143(1):69-93. PubMed ID: 31828288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocalcin Delta Suppression Protects against Spinal Muscular Atrophy in Humans and across Species by Restoring Impaired Endocytosis.
    Riessland M; Kaczmarek A; Schneider S; Swoboda KJ; Löhr H; Bradler C; Grysko V; Dimitriadi M; Hosseinibarkooie S; Torres-Benito L; Peters M; Upadhyay A; Biglari N; Kröber S; Hölker I; Garbes L; Gilissen C; Hoischen A; Nürnberg G; Nürnberg P; Walter M; Rigo F; Bennett CF; Kye MJ; Hart AC; Hammerschmidt M; Kloppenburg P; Wirth B
    Am J Hum Genet; 2017 Feb; 100(2):297-315. PubMed ID: 28132687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The analysis of the association between the copy numbers of survival motor neuron gene 2 and neuronal apoptosis inhibitory protein genes and the clinical phenotypes in 40 patients with spinal muscular atrophy: Observational study.
    Zhang Y; He J; Zhang Y; Li L; Tang X; Wang L; Guo J; Jin C; Tighe S; Zhang Y; Zhu Y; Zhu B
    Medicine (Baltimore); 2020 Jan; 99(3):e18809. PubMed ID: 32011487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical validation of the droplet digital PCR assay for diagnosis of spinal muscular atrophy.
    Park S; Lee H; Shin S; Lee ST; Lee KA; Choi JR
    Clin Chim Acta; 2020 Nov; 510():787-789. PubMed ID: 32956702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SMN1 common variant c.22 dupA in Chinese patients causes spinal muscular atrophy by nonsense-mediated mRNA decay in humans.
    Bai J; Qu Y; Cao Y; Yang L; Ge L; Jin Y; Wang H; Song F
    Gene; 2018 Feb; 644():49-55. PubMed ID: 29080838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense oligonucleotides targeting the SMN2 promoter region enhance SMN2 expression in spinal muscular atrophy cell lines and mouse model.
    Wang J; Bai J; OuYang S; Wang H; Jin Y; Peng X; Ge X; Jiao H; Zou J; He C; Xiao P; Song F; Qu Y
    Hum Mol Genet; 2022 May; 31(10):1635-1650. PubMed ID: 34888619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The zinc finger protein ZPR1 is a potential modifier of spinal muscular atrophy.
    Ahmad S; Wang Y; Shaik GM; Burghes AH; Gangwani L
    Hum Mol Genet; 2012 Jun; 21(12):2745-58. PubMed ID: 22422766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.